Treatment Choices for Slip Disc at Gokuldas Hospital
Ageing and MS.docx
1. Running head; Ageing and multiple sclerosis 1
Ageing and multiple sclerosis
Name
Institution affiliation
2. Ageing and multiple sclerosis 2
Ageing and multiple sclerosis
Multiple sclerosis (MS) is an immune-mediated illness that affects the central nervous
system, i.e. the spinal cord and the brain which begins at an early age, especially young
adulthood. It attacks the myelin, which covers nerve fibers, thus causing communication
difficulties between the mind and the body. The disease may cause permanent damage to the
nerves or even deteriorate them. Healthcare should, then, disclose the complications of
identifying and treating age-linked comorbidities overlying on the condition. (Sanai et al., 2016
p.717) Also, healthcare should know how some multiple sclerosis symptoms relate with the
ageing process. Different diagnosis will help the physicians to choose the most suitable
therapeutic method.
Ageing is a substantial aspect that influences the development of multiple sclerosis.
Patients with the condition over the age of 65 years are more likely to have a progressive course
primary progressive, 29%; secondary progressive, 26%; or progressive relapsing, 8% when
equated to the younger patients of whom 57% have relapsing-remitting Multiple sclerosis. (Sanai
et al., 2016 p.717) Ageing increases the risk of this disease. People with older age are at high risk
of MS. Long waits in time when a symptom begins and diagnosis in older age is linked to
cardiovascular comorbidities. The disease progresses with advancing age. As an individual age,
there are many age-related diseases such as cancers and viral infections and other related
disorders due to the altered immune responses. (Sanai et al. 2016 p.719) It becomes challenging
at it becomes hard to differentiate between the normal ageing and healthy ageing process. Hence
while ageing there is an increase in the risk of alteration to progressive stage, though there is a
significant minority, about one third who persist in the relapsing-remitting progress as they age.
3. Ageing and multiple sclerosis 3
The mean age of the multiple sclerosis is growing. There are increased numbers of aged
patients with MS, which is expected for assessing. Physicians should have awareness on the
effects of old age inception and proceeding age on the medical demonstration and progression of
MS. They should aim at understanding how to differentiate typical ageing cases from
deteriorating MS. They should also find other nervous disorders that are developing as one in
ages. Maybe they, however, sham some of the numerous symptoms of multiple sclerosis. (Sanai
et al. 2016 p.722) Care providers ought to have a high extent of doubt of despair, nervousness,
and weariness outlook occurrence and other related ill effects. Patients with MS should be
screened regularly. They should be taken care of and given enough social support.
4. Ageing and multiple sclerosis 4
References
Sanai, S. A., Saini, V., Benedict, R. H., Zivadinov, R., Teter, B. E., Ramanathan, M., &
Weinstock-Guttman, B. (2016). Ageing and multiple sclerosis. Multiple Sclerosis Journal, 22(6),
717–725. https://doi.org/10.1177/1352458516634871